SCHEMBL6999775

SCHEMBL6999775

CCOC(=O)Nc1cccc(Cl)c1C(=O)O

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.71
HPGD P15428 1/20 0.55
NLRP3 Q96P20 2/20 0.52
PLK1 P53350 1/20 0.51
TRPM4 Q8TD43 1/20 0.50
GPR35 Q9HC97 1/20 0.49
PBRM1 Q86U86 1/20 0.49
CYP1A2 P05177 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
HTT P42858 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
MAPT P10636 2/20 0.47
FABP3 P05413 1/20 0.47
FABP4 P15090 1/20 0.47
LMNA P02545 1/20 0.47
MAPK1 P28482 1/20 0.47
HSD17B10 Q99714 1/20 0.47
KDM4E B2RXH2 1/20 0.46
PTPN1 P18031 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13602372 0.88 ALDH1A1 (0.71) ALDH1A1HPGDNLRP3GPR35CYP1A2
SCHEMBL10489654 0.85 ALDH1A1 (0.57) ALDH1A1HPGDNLRP3TRPM4CYP1A2
SCHEMBL8657531 0.84 ALDH1A1 (0.56) ALDH1A1HPGDNLRP3PLK1CYP1A2
SCHEMBL10489851 0.84 ALDH1A1 (0.56) ALDH1A1HPGDNLRP3CYP1A2CYP2C9
SCHEMBL3803167 0.83 ALDH1A1 (0.77) ALDH1A1HPGDNLRP3GPR35CYP1A2
SCHEMBL1189632 0.83 ALDH1A1 (0.77) ALDH1A1HPGDNLRP3CYP1A2CYP2C9
SCHEMBL27474459 0.82 ALDH1A1 (0.62) ALDH1A1HPGDNLRP3CYP1A2CYP2C9
SCHEMBL3788964 0.82 ALDH1A1 (0.75) ALDH1A1HPGDNLRP3GPR35CYP1A2
SCHEMBL3784358 0.81 ALDH1A1 (0.73) ALDH1A1HPGDNLRP3GPR35CYP1A2
SCHEMBL10489823 0.80 NLRP3 (0.60) ALDH1A1HPGDNLRP3CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0980374-B1 PHOSPHODIESTERASE 4-INHIBITING DIAZEPINOINDOLONES PFIZER HOLDING FRANCE (FR) 2003-02-12 EP disclosed
US-6239130-B1 ASTHMA, ATOPIC DERMATITIS, RHEUMATOID ARTHRITIS, INFLAMMATORY BOWEL DISORDERS, PULMONARY HYPERTENSION, LIVER INJURY, BONE LOSS, SEPTIC SHOCK, OR MULTIPLE SCLEROSIS, WARNER-LAMBERT COMPANY 2001-05-29 US disclosed
EP-0980374-A1 PHOSPHODIESTERASE 4-INHIBITING DIAZEPINOINDOLONES PARKE-DAVIS (FR) 2000-02-23 EP disclosed
WO-1998049169-A1 PHOSPHODIESTERASE 4-INHIBITING DIAZEPINOINDOLONES PARKE-DAVIS (FR) 1998-11-05 WO disclosed